Héctor Rodríguez-Angulo1, Juan Marques2, Ivan Mendoza2, Marco Villegas3, Alfredo Mijares4, Núria Gironès5, Manuel Fresno5. 1. Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela. hrodrigu@ivic.gob.ve. 2. Instituto de Medicina Tropical, Caracas, Venezuela. 3. Universidad de Castilla la Mancha, Ciudad Real, Spain. 4. Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela. 5. Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.
Abstract
BACKGROUND: Chagas disease is caused by the protozoan Trypanosoma cruzi and is characterized by heart failure and sudden death. Identifying which factors are involved in evolution and treatment response is actually challenging. Thus, the aim of this work was to determine the Th1/Th17 (IL-6, IL-2, TNF, IL-17 and IFN-γ) and Th2 (IL-4 and IL-10) serum profile in Venezuelan Chagasic patients stratified according amiodarone treatment, hypertension and arrhythmias. METHODS: Sera from 38 chagasic patients were analyzed to determine the level of cytokines by Multiplexed Bead-Based Immunoassays. ANOVA test was applied to determine differences for each group. Additionally, a Linear Discriminant Analysis (LDA) was applied to observe the accuracy of different cytokines to discriminate between the groups. RESULTS: The levels of several cytokines were significantly higher in the high-risk of sudden death and untreated group. LDA showed that IL-2, IFN-γ and IL-10 were the best cytokines for discriminating between high-risk of sudden death and untreated patients versus low-risk of sudden death, treated and control groups. CONCLUSIONS: High IL-2 levels seem to identify patients with high-risk of sudden death and seems adequate as treatment efficacy marker. To our knowledge, this is the first report about the anti-inflammatory role of the amiodarone in Chagas disease, suggesting an inmunomodulatory effect that may be exploited as coadjutant therapy in chronic Chagas disease.
BACKGROUND:Chagas disease is caused by the protozoan Trypanosoma cruzi and is characterized by heart failure and sudden death. Identifying which factors are involved in evolution and treatment response is actually challenging. Thus, the aim of this work was to determine the Th1/Th17 (IL-6, IL-2, TNF, IL-17 and IFN-γ) and Th2 (IL-4 and IL-10) serum profile in Venezuelan Chagasic patients stratified according amiodarone treatment, hypertension and arrhythmias. METHODS: Sera from 38 chagasic patients were analyzed to determine the level of cytokines by Multiplexed Bead-Based Immunoassays. ANOVA test was applied to determine differences for each group. Additionally, a Linear Discriminant Analysis (LDA) was applied to observe the accuracy of different cytokines to discriminate between the groups. RESULTS: The levels of several cytokines were significantly higher in the high-risk of sudden death and untreated group. LDA showed that IL-2, IFN-γ and IL-10 were the best cytokines for discriminating between high-risk of sudden death and untreated patients versus low-risk of sudden death, treated and control groups. CONCLUSIONS: High IL-2 levels seem to identify patients with high-risk of sudden death and seems adequate as treatment efficacy marker. To our knowledge, this is the first report about the anti-inflammatory role of the amiodarone in Chagas disease, suggesting an inmunomodulatory effect that may be exploited as coadjutant therapy in chronic Chagas disease.
Authors: Daniel Adesse; Eduardo Meirelles Azzam; Maria de Nazareth L Meirelles; Julio A Urbina; Luciana R Garzoni Journal: Antimicrob Agents Chemother Date: 2010-11-15 Impact factor: 5.191
Authors: Simone Garcia; Carolina O Ramos; Juliana F V Senra; Fabio Vilas-Boas; Maurício M Rodrigues; Antonio C Campos-de-Carvalho; Ricardo Ribeiro-Dos-Santos; Milena B P Soares Journal: Antimicrob Agents Chemother Date: 2005-04 Impact factor: 5.191
Authors: Renzo Salazar; Ricardo Castillo-Neyra; Aaron W Tustin; Katty Borrini-Mayorí; César Náquira; Michael Z Levy Journal: Am J Trop Med Hyg Date: 2014-11-17 Impact factor: 2.345
Authors: Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman Journal: Annu Rev Pathol Date: 2018-10-24 Impact factor: 23.472
Authors: Aniélen D Silva; Nathieli B Bottari; Guilherme M do Carmo; Matheus D Baldissera; Carine F Souza; Vanessa S Machado; Vera M Morsch; Maria Rosa C Schetinger; Ricardo E Mendes; Silvia G Monteiro; Aleksandro S Da Silva Journal: Mol Cell Biochem Date: 2017-08-01 Impact factor: 3.396